ArticleMolecular genetics and metabolism reports2017

Pilot study of the safety and effect of adalimumab on pain, physical function, and musculoskeletal disease in mucopolysaccharidosis types I and II.

Lynda E Polgreen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.